Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer.
News | Radiation Therapy | May 11, 2021
New Marker Predicts Benefit of Radiotherapy for Early-stage Breast Cancer
May 11, 2021 —A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that...
read more
GE Healthcare announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare. The company aims to develop and bring to market Zionexa’s pipeline biomarkers, as well as the recently FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18)
News | PET Imaging | May 06, 2021
GE Healthcare Acquires Zionexa
May 6, 2021 — GE Healthcare announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology...
read more
News | Radiation Therapy | May 06, 2021
Low Doses of Radiation May Improve Quality of Life for Those with Severe Alzheimer's
May 6, 2021 — Individuals living with severe Alzheimer's disease showed remarkable improvements in behavior and...
read more
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
Calculator That Predicts Risk of Lung Cancer Underperforms in Diverse Populations
May 5, 2021 — Lung cancer is the third most common cancer in the U.S. and the leading cause of cancer death, with about...
read more
The emergence of #therapeutic #radiopharmaceuticals and its adoption in #cancer care provide one more weapon in combating cancer

Getty Images

Feature | Radiation Oncology | May 04, 2021 | By Vinay Shivaprasad
The Rise of Therapeutic Radiopharmaceuticals
The term nuclear medicine is associated with the diagnostic procedures single-photon emission computed tomography (...
read more
Molli provides breast cancer patients with a better experience over traditional wire and other lesion localization options; the new device helps surgeons remove lesions more efficiently with accuracy and specificity
News | Breast Imaging | May 03, 2021
Molli Surgical Announces FDA Clearance for MOLLI Wire-free Localization Technology for Breast Cancer Surgery
May 3, 2021 — Molli Surgical Inc. announced U.S. Food and Drug Administration (FDA) clearance for Molli, a new wire-...
read more
Despite receiving high radiation doses to their tumors, lung cancer patients treated with technique that spares a large part of the esophagus did not develop severe inflammation of the esophagus

Getty Images

News | Lung Imaging | April 30, 2021
Sculpting Radiation Beam Spares Lung Cancer Patients from Severe, Disabling Complication
April 30, 2021 — For many patients with localized lung cancer (non-small-cell lung carcinoma and small cell lung...
read more
#prostatecancer During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

Getty Images

News | Prostate Cancer | April 30, 2021
Decrease in Prostate Cancer Diagnoses Due to Pandemic
April 30, 2021 — During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer...
read more
A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
Help Spread Awareness of Potential COVID-19 Vaccine Imaging Side-effects
Ever so slowly, we are beginning to see some light at the end of the pandemic’s tunnel. Vaccines are now more easily...
read more
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.

Image courtesy of Accuray

News | Stereotactic Body Radiation Therapy (SBRT) | April 23, 2021
Study Finds Stereotactic Body Radiotherapy Safe for Treating Patients with Multiple Metastases
April 23, 2021 — A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the...
read more
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
New Study Reveals Targeted Therapy Working in Early Breast Cancer
April 22, 2021 — Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate,...
read more
olecular Targeting Technologies, Inc. (MTTI) announced the issuance of United States Patent # 10,953,113. The patent claims a quick (5 min), easy and quantitative conversion of commercially available 18F-deoxyglucose (18F-FDG) to 18F-Fluroglucaric acid (18F-FGA).

Getty Images

News | PET Imaging | April 19, 2021
Molecular Targeting Technologies, Inc. Announces New PET Imaging Agent
April 19, 2021 — Molecular Targeting Technologies, Inc. (MTTI) announced the issuance of United States Patent # 10,953,...
read more
#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
Siemens Healthineers Completes Acquisition of Varian
April 15, 2021 — Siemens Healthineers AG announced that it has successfully completed the acquisition of Varian Medical...
read more
The U.S. Food and Drug Administration (#FDA) authorized marketing of #Medtronic's #GIGenius, the first device that uses #artificialintelligence (#AI) based on #machinelearning to assist #clinicians in detecting #lesions (such as #polyps or suspected tumors) in the #colon in real time during a c#olonoscopy.

The GI Genius intelligent endoscopy module works in real-time, automatically identifying and marking (with a green box) abnormalities consistent with colorectal polyps, including small flat polyps.

News | Artificial Intelligence | April 12, 2021
FDA Authorizes Marketing of First Device that Uses AI to Help Detect Potential Signs of Colon Cancer
April 12, 2021 — The U.S. Food and Drug Administration (FDA) authorized marketing of Medtronic's GI Genius, the first...
read more
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine...
read more
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer
April 8, 2021 — Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI...
read more
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
Mobidiag to be Acquired by Hologic for $795M
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular...
read more
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
Vysioneer Receives FDA Clearance on First-Ever Tumor Auto-Contouring Solution for Radiation Therapy
April 7, 2021 — Vysioneer, a leader in artificial intelligence (AI) for cancer care, announced it received the U.S....
read more
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
News | Radiation Therapy | March 31, 2021
ASTRO Survey Finds Pandemic Has Led to More Advanced-stage Cancer Diagnoses
March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced...
read more
Ultimately, because LYFS-CT may exclude minority patients who could benefit from LCS and underestimate the benefits of LCS, the authors of this AJR article suggested "augmenting LCS eligibility for minority patients using combinations of models"--specifically, the PLCOm2012 model in conjunction with LYFS-CT and USPSTF-2020. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Ultimately, because LYFS-CT may exclude minority patients who could benefit from LCS and underestimate the benefits of LCS, the authors of this AJR article suggested "augmenting LCS eligibility for minority patients using combinations of models"--specifically, the PLCOm2012 model in conjunction with LYFS-CT and USPSTF-2020. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Lung Imaging | March 29, 2021
Risk Prediction to Reduce Minority Disparities in USPSTF Lung Cancer Screening Guidelines
March 29, 2021 — According to ARRS' American Journal of Roentgenology (AJR), updated United States Preventive Services...
read more
© Copyright Wainscot Media. All Rights Reserved.